Zai Lab (NASDAQ: ZLAB) insider transactions
In the twelve months to 10 November 2026, executives and directors of Zai Lab reported 39 open-market sales of 571,166 shares ($11.1m) and 2 open-market purchases of 3,467 shares ($65,804), by 7 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Chen Yajing | Chief Financial Officer | Option exercise | +920 | — | 36,555 | Form 4 |
| 1 October 2026 | Chen Yajing | Chief Financial Officer | Shares withheld for tax | −315 | $25.50 | 36,240 | Form 4 |
| 19 August 2026 | Chen Yajing | Chief Financial Officer | Open-market sale | −260 | $27.00 | 35,635 | Form 4 |
| 14 August 2026 | Chen Yajing | Chief Financial Officer | Option exercise | +1,250 | — | 36,322 | Form 4 |
| 14 August 2026 | Chen Yajing | Chief Financial Officer | Shares withheld for tax | −427 | $25.90 | 35,895 | Form 4 |
| 12 August 2026 | Lis William | Director | Open-market sale | −8,506 | $25.00 | 41,931 | Form 4 |
| 11 August 2026 | Chen Yajing | Chief Financial Officer | Open-market sale | −619 | $25.00 | 35,072 | Form 4 |
| 2 July 2026 | Du Ying | Chairperson & CEO | Option exercise | +11,048 | — | 1,225,749 | Form 4 |
| 2 July 2026 | Du Ying | Chairperson & CEO | Shares withheld for tax | −4,348 | $19.12 | 1,221,401 | Form 4 |
| 1 July 2026 | Du Ying | Chairperson & CEO | Option exercise | +18,000 | — | 1,221,784 | Form 4 |
| 1 July 2026 | Du Ying | Chairperson & CEO | Shares withheld for tax | −7,083 | $19.15 | 1,214,701 | Form 4 |
| 1 July 2026 | Gaynor Richard | Director | Open-market purchase | +1,736 | $19.05 | 80,737 | Form 4 |
| 30 June 2026 | Du Ying | Chairperson & CEO | Open-market sale | −7,026 | $18.53 | 1,203,784 | Form 4 |
| 29 June 2026 | Du Ying | Chairperson & CEO | Option exercise | +17,970 | — | 1,210,810 | Form 4 |
| 26 June 2026 | Chen Yajing | Chief Financial Officer | Open-market sale | −2,264 | $17.46 | 35,691 | Form 4 |
| 26 June 2026 | Du Ying | Chairperson & CEO | Open-market sale | −24,543 | $17.46 | 1,192,840 | Form 4 |
| 26 June 2026 | Edmondson Frazor Titus III | Chief Legal Officer | Open-market sale | −4,103 | $17.46 | 30,346 | Form 4 |
| 25 June 2026 | Chen Yajing | Chief Financial Officer | Option exercise | +6,250 | — | 37,955 | Form 4 |
| 25 June 2026 | Du Ying | Chairperson & CEO | Option exercise | +58,800 | — | 1,217,383 | Form 4 |
| 25 June 2026 | Edmondson Frazor Titus III | Chief Legal Officer | Option exercise | +14,600 | — | 34,449 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Zai Lab page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.